<scp>UBE2T</scp> promotes glioblastoma malignancy through ubiquitination‐mediated degradation of <scp>RPL6</scp>-Reference-Cited by-同舟云学术

UBE2T promotes glioblastoma malignancy through ubiquitination‐mediated degradation of RPL6

Published:2022-10-14 Issue:2 Volume:114 Page:521-532
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Science

Author:

Tao Xuxiu¹²,Wu Xia²³,Zhou Peijun¹²,Yu Xuehui¹²,Zhao Chen¹²,Peng Xingzhi¹²,Zhang Kun¹,Shen Liangfang¹^ORCID,Peng Jinwu⁴⁵,Yang Lifang¹²^ORCID

Affiliation:

1. Department of Oncology Key Laboratory of Carcinogenesis and Cancer Invasion of Ministry of Education, National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University Changsha China

2. Cancer Research Institute, School of Basic Medicine Science, Central South University Changsha China

3. Department of Pathology The Second Xiangya Hospital, Central South University Changsha China

4. Department of Pathology Xiangya Hospital, Central South University Changsha China

5. Department of Pathology Xiangya Changde Hospital Changde China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cas.15604

Reference42 articles.

1. The 2021 WHO Classification of Tumors of the Central Nervous System: a summary

2. Pathogenetic Features and Current Management of Glioblastoma

3. The Current State of Oncolytic Herpes Simplex Virus for Glioblastoma Treatment

4. Regulation of gene expression by the ubiquitin-proteasome system

5. Ubiquitin becomes ubiquitous in cancer

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CRISPRi screen of long non-coding RNAs identifies LINC03045 regulating glioblastoma invasion;PLOS Genetics;2024-06-10

2. Identification of small‐molecule binding sites of a ubiquitin‐conjugating enzyme‐UBE2T through fragment‐based screening;Protein Science;2024-02-15

3. CircNUP50 is a novel therapeutic target that promotes cisplatin resistance in ovarian cancer by modulating p53 ubiquitination;Journal of Nanobiotechnology;2024-01-19

4. Emerging trends in post-translational modification: Shedding light on Glioblastoma multiforme;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2023-11

5. Backbone 1H, 15N and 13C resonance assignments for an E2 ubiquitin conjugating enzyme-UBE2T;Biomolecular NMR Assignments;2023-09-29